A New Approach to the Management of Anemia in CKD Patients: A Review on Roxadustat

Advances in Therapy - United States
doi 10.1007/s12325-017-0508-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD

American Journal of Kidney Diseases
Nephrology
2017English

A New Approach to Periodontal Management

British Dental Journal
Dentistry
2020English

Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

Advances in Therapy
MedicinePharmacology
2019English

Management of Hyperglycemia, Dyslipidemia, and Albuminuria in Patients With Diabetes and CKD: A Systematic Review for a KDOQI Clinical Practice Guideline

American Journal of Kidney Diseases
Nephrology
2012English

A Retrospective Review of Blood Transfusions in Cancer Patients With Anemia

Oncologist
Cancer ResearchMedicineOncology
1999English

Effect of Achieved Hemoglobin Level on Renal Outcome in Non-Dialysis Chronic Kidney Disease (CKD) Patients Receiving Epoetin Beta Pegol: MIRcerA CLinical Evidence on Renal Survival in CKD Patients With Renal Anemia (MIRACLE-CKD Study)

Clinical and Experimental Nephrology
PhysiologyNephrology
2018English

A New Approach to Determine the Distributional Effects of Quota Management in Fisheries

Fisheries Research
Aquatic Science
2016English

Effectiveness of Multifaceted Care Approach on Adverse Clinical Outcomes in Nondiabetic CKD: A Systematic Review and Meta-Analysis

Kidney International Reports
Nephrology
2017English

Bone Disease in CKD: A Focus on Osteoporosis Diagnosis and Management

American Journal of Kidney Diseases
Nephrology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy